Genenta Science SpA ADR (GNTA) Stock Analysis

Genenta Science SpA ADR (GNTA) is a publicly traded company in the HEALTHCARE sector. It trades at $2.20, carries a market capitalization of $24.30M. This page summarizes the public market data, fundamentals, and frequently asked questions for GNTA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.20
• Market Cap: $24.30M
• EPS: $-0.38
• 52-Week High: $6.20
• 52-Week Low: $0.55

Market Sentiment

Genenta Science SpA ADR currently has a Bullish sentiment score of 0.35.

About Genenta Science SpA ADR

Genenta Science SpA (GNTA) is a clinical-stage biotechnology company headquartered in Milan, Italy, specializing in hematopoietic stem cell gene therapies for solid tumor treatment. By employing advanced genetic engineering techniques, Genenta is at the forefront of developing innovative cancer therapies that aim to significantly transform existing treatment paradigms. With a strong pipeline of product candidates and strategic partnerships, the company is strategically positioned to meet urge...

GNG Research Analysis

GNG Research scores Genenta Science SpA ADR (GNTA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GNTA.

Frequently Asked Questions

Does GNTA pay dividends?

Genenta Science SpA ADR (GNTA) does not currently pay a regular dividend.

What is GNTA's market cap?

Genenta Science SpA ADR (GNTA) has a market capitalization of $24.30M with a current stock price of $2.20.